Alternative TFAP2A isoforms have distinct activities in breast cancer - Wikidata - awgldk - TriplyDB

Alternative TFAP2A isoforms have distinct activities in breast cancer

Alternative TFAP2A isoforms have distinct activities in breast cancer

http://www.wikidata.org/entity/Q35558927

about

Sumoylation pathway is required to maintain the basal breast cancer subtype The BTB-containing protein Kctd15 is SUMOylated in vivo Inhibition of neural crest formation by Kctd15 involves regulation of transcription factor AP-2 Recursive Random Lasso (RRLasso) for Identifying Anti-Cancer Drug Targets Transcriptional regulation prediction of antiestrogen resistance in breast cancer based on RNA polymerase II binding data.TFAP2A is a component of the ZEB1/2 network that regulates TGFB1-induced epithelial to mesenchymal transition HIPSTR and thousands of lncRNAs are heterogeneously expressed in human embryos, primordial germ cells and stable cell lines Histone demethylase KDM5B collaborates with TFAP2C and Myc to repress the cell cycle inhibitor p21(cip) (CDKN1A).Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors Negative regulation of activity of TFAP2 (AP-2) family transcription factors TFAP2C promotes stemness and chemotherapeutic resistance in colorectal cancer via inactivating hippo signaling pathway.SUMOylation of TFAP2A with SUMO1 Zinc-finger protein 471 suppresses gastric cancer through transcriptionally repressing downstream oncogenic PLS3 and TFAP2A.CITED2-mediated human hematopoietic stem cell maintenance is critical for acute myeloid leukemia.

P2860

Q24297866-FB18736A-C1AD-49CA-B638-8D6E14D79F19 Q28312139-2E088F8D-EF77-4A2D-94FB-ED1ABA573269 Q28312142-382198E3-C373-4892-ADD4-FF5C66E4037B Q28550739-D089BA52-7474-4712-A44B-C8875D435BA1 Q30763243-3581ABCB-2B78-4FBE-8450-33DA504BA8F5 Q33568354-035DC257-EE19-4C0A-AE1D-6AB8E2C5121D Q34539755-9BBD04CB-87FC-4C9F-A7C3-8A37C931008C Q39389047-1E634337-A651-4D9D-A453-3102707D063D Q45316793-E69AED38-C253-491A-97EB-85D3BCC2DCA4 Q45316801-10D6764B-D643-4B20-BDE2-241575C92E7E Q49802266-1F62AC8F-7B82-48B8-BEC0-D2783FEC9B70 Q50290465-EBF1CF55-5F7D-4F99-97D7-3F0EAD1FD99E Q53176450-7DF2A7CE-2721-445F-84ED-7522D3127AFE Q54325366-70ADA98A-4AD0-4D1A-887E-8AC2FEC1A3D1

P2860

Alternative TFAP2A isoforms have distinct activities in breast cancer

http://www.wikidata.org/entity/Q35558927

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Alternative TFAP2A isoforms have distinct activities in breast cancer

@ast

Alternative TFAP2A isoforms have distinct activities in breast cancer

@en

type

label

Alternative TFAP2A isoforms have distinct activities in breast cancer

@ast

Alternative TFAP2A isoforms have distinct activities in breast cancer

@en

prefLabel

Alternative TFAP2A isoforms have distinct activities in breast cancer

@ast

Alternative TFAP2A isoforms have distinct activities in breast cancer

@en

P1433

Q35558927-3F640EC2-F001-460D-99FA-A82E0420342F

P1476

Q35558927-159BB07B-724C-453F-8720-DC96D346F503

P2093

Q35558927-06ADF97D-3EA1-42E7-A828-6D0EAD09FF8C

Q35558927-51C6E1FA-2BE4-41BB-A94F-DD620E931C4C

Q35558927-5E2A3E22-D432-4A82-8001-452038EE700A

Q35558927-86A72ED0-DCAF-4648-B130-E781726EE3C2

Q35558927-8AFF7C83-5A1D-41A7-94FA-235B1A66398A

Q35558927-C3854C85-8711-487D-8FA0-04CB763E88EC

P2860

Q35558927-0C0AE152-CFC9-46AF-A4AF-73FE3890B38A

Q35558927-118201D5-2CA5-4ABB-BB74-692119E56B8C

Q35558927-1B1D050E-9C46-46E2-A078-9D553849EDE3

Q35558927-204A78A8-F136-4DDD-8FD8-76763AF20371

Q35558927-29BBF4F9-B81B-4074-800A-F2B6740E3ECB

Q35558927-3188B2B3-2970-4E8C-AD15-D7AEA6C9085C

Q35558927-34612F8A-D3E9-451D-95C9-AF1B324994B5

Q35558927-3959505C-D5E8-4BE1-BF33-90E7CA5FB6F5

Q35558927-4A2A9BBE-38E0-4844-9F2F-F6F1CD723D18

Q35558927-564419F6-EB33-4B44-9F3D-08647639B7AE

P2888

Q35558927-74910184-7BA0-4D5F-B22B-DD0CC8ECEBC1

P304

Q35558927-6387561D-178E-4CEA-9C9C-A44B04D322AC

P31

Q35558927-7091BC73-8905-4241-8E34-110928D2F83E

P356

Q35558927-0A7ED47A-BC8D-4812-A726-F571B655F156

P433

Q35558927-B5BD832D-21A6-43D8-A71E-79A379318589

P478

Q35558927-CD342FB1-D673-4990-9159-DD74AFC4C54C

P577

Q35558927-2885D3E9-29E1-4DA3-8083-9A47A0CAFEB4

P5875

Q35558927-8B845D72-96BC-43E5-860E-0473EC66A3C3

P6179

Q35558927-E07DB3BA-749F-4B03-8DC5-13A6260623C9

P698

Q35558927-D0AA505F-0162-4475-9E00-B0B8D7BF1627

P932

Q35558927-20BBBE7B-814A-4963-9401-B84E0EE85D18

P356

P1433

Breast Cancer Research

P1476

Alternative TFAP2A isoforms have distinct activities in breast cancer

@en

P2093

Angelo G Scibetta

http://www.w3.org/2001/XMLSchema#string

Anna M Price

http://www.w3.org/2001/XMLSchema#string

Chiara Berlato

http://www.w3.org/2001/XMLSchema#string

Helen C Hurst

http://www.w3.org/2001/XMLSchema#string

KaYi V Chan

http://www.w3.org/2001/XMLSchema#string

Monica Canosa

http://www.w3.org/2001/XMLSchema#string

P2860

The AP-2 family of transcription factors

Cardiac malformations, adrenal agenesis, neural crest defects and exencephaly in mice lacking Cited2, a new Tfap2 co-activator

Physical and functional interactions among AP-2 transcription factors, p300/CREB-binding protein, and CITED2

Transcription factor AP-2 interacts with the SUMO-conjugating enzyme UBC9 and is sumolated in vivo

Derepression of the C/EBPalpha gene during adipogenesis: identification of AP-2alpha as a repressor

AP-2alpha: a regulator of EGF receptor signaling and proliferation in skin epidermis

Human CREB-binding protein/p300-interacting transactivator with ED-rich tail (CITED) 4, a new member of the CITED family, functions as a co-activator for transcription factor AP-2

Concepts in sumoylation: a decade on

Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures

Novel activator protein-2alpha splice-variants function as transactivators of the ovine placental lactogen gene.

P2888

P304

R23

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/BCR2838

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50286956

http://www.w3.org/2001/XMLSchema#string

P6179

1035164690

http://www.w3.org/2001/XMLSchema#string

P698

21375726

http://www.w3.org/2001/XMLSchema#string

P932

3219183

http://www.w3.org/2001/XMLSchema#string